Peter Dorff

Peter Dorff has a strong background in the pharmaceutical industry. Peter is currently the Head of Commercial Insights, Analytics, and Sales Operations at Kura Oncology, Inc. Prior to that, they held leadership positions at Array BioPharma Inc., Pfizer, and AstraZeneca. At AstraZeneca, they served as the Head of Lynparza Insights & Analytics - Oncology, leading a team through successful launches and overseeing various marketing and analytical activities. Peter also served in roles such as Forecasting and Performance Leader and Senior Market Research Manager. Before joining AstraZeneca, they worked at AstraZeneca R&D as a Regulatory Affairs Manager and Senior Associate Scientist.

Peter Dorff obtained their Honors BSc in Biochemistry and Chemistry from Western University, which they attended from 1996 to 2000. Following that, they pursued a Master of Science (MS) in Chemistry from McMaster University, where they studied from 2000 to 2002. Later, in 2008, they began their MBA at the University of Delaware, which they completed in 2010.